Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

pheochromocytoma News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

Recent research using single-cell transcriptomics has uncovered significant transcriptional reprogramming and microenvironmental changes in ectopic ACTH/CRH-secreting pheochromocytomas. These findings could enhance understanding of tumor biology and inform future therapeutic strategies.

A case report highlights pediatric pheochromocytoma characterized by rapid cyclic blood pressure fluctuations. This study contributes to the understanding of this rare tumor's clinical presentation in children.

A recent study highlights the diagnostic challenges of PTHrP-mediated hypercalcemia in metastatic adrenocortical carcinoma, which can mimic pheochromocytoma. This research underscores the need for careful differentiation in clinical settings.

A new publication explores future scenarios for radioligand therapy in treating pheochromocytomas and paragangliomas. This research highlights potential advancements in targeted therapies for these rare tumors.

A recent case report highlights a rare instance of pheochromocytoma presenting as acute coronary syndrome, leading to cardiogenic shock. This case underscores the importance of considering rare diseases in differential diagnoses.

A narrative review explores the integration of developmental biology with translational technologies in the study of paragangliomas and pheochromocytomas. This research may provide insights into the underlying mechanisms and potential therapeutic approaches for these rare tumors.

Recent research highlights the role of molecular clusters in advancing precision medicine for pheochromocytomas and paragangliomas. This study may pave the way for more targeted therapies in these rare tumors.

Recent research highlights belzutifan, a hypoxia-inducible factor 2-alpha inhibitor, as a potential treatment for patients with advanced pheochromocytoma and paraganglioma. This study contributes to the understanding of targeted therapies for these rare tumors.

New research identifies biomarkers associated with metastatic disease in pheochromocytoma and paraganglioma, potentially aiding in diagnosis and treatment strategies. This study enhances understanding of these rare tumors and their progression.

A case report details the use of ex situ hepatectomy and autologous liver transplantation for a patient with recurrent pheochromocytoma invading the retrohepatic vena cava. This innovative approach may provide insights into surgical options for complex cases of this rare tumor.

Recent research highlights advancements in molecular imaging and radioligand therapies for pheochromocytomas and paragangliomas. These findings could enhance diagnostic and therapeutic strategies for these rare tumors.

Recent research highlights systemic management strategies for adrenal malignancies, specifically adrenocortical carcinoma and pheochromocytoma/paraganglioma. This study contributes to the understanding of treatment approaches for these rare cancers.

A systematic review and meta-analysis identifies key prognostic factors for cardiovascular complications in patients with pheochromocytomas and paragangliomas induced by catecholamines. This research enhances understanding of the risks associated with these rare tumors.

A case report highlights severe arrhythmia as a complication of takotsubo cardiomyopathy, revealing an underlying pheochromocytoma. This finding underscores the need for careful evaluation of arrhythmias in patients with takotsubo syndrome.

A new study reports clinical and biochemical variability in composite pheochromocytomas through three case analyses. This research contributes to the understanding of this rare tumor type and its diverse presentations.

A recent study highlights the diagnostic challenges of recurrent Takotsubo syndrome and pulmonary embolism as indicators of pheochromocytoma. This research underscores the need for heightened awareness among clinicians to avoid misdiagnosis.

A new study addresses the analytical challenges in the biochemical diagnosis of pheochromocytoma and paraganglioma, highlighting the need for optimization in diagnostic methods. This research could enhance the accuracy of diagnosing these rare tumors.

A study published in PubMed analyzes the incidence of pheochromocytoma and paraganglioma, comparing familial and sporadic cases at a single center in Portugal. The findings contribute to understanding the epidemiology of these rare tumors.

Recent research highlights the genetic and clinical characteristics of pheochromocytomas and paragangliomas, shedding light on their pathophysiology. This study contributes to the understanding of these rare tumors and may inform future therapeutic strategies.

Recent research highlights advancements in precision imaging and therapies for paragangliomas and pheochromocytomas, focusing on molecular diagnostics and imaging-guided management. These developments may enhance treatment strategies for patients with these rare tumors.

Not rare diseases news,news about your rare disease.